Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy Report from the 2021 SH/EAHP Workshop

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Discuss the impact of rearranged KMT2A on lineage switch in B-acute lymphoblastic leukemia (B-ALL).
List clinical features associated with...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Discuss the impact of rearranged KMT2A on lineage switch in B-acute lymphoblastic leukemia (B-ALL).
List clinical features associated with transdifferentiation of B-ALL.
Describe the impact of molecular phenotype and treatment of B-ALL on the development of transdifferentiation.

View More View Less